Cost-effectiveness of deep brain stimulation versus treatment as usual for obsessive-compulsive disorder-Reference-Cited by-同舟云学术

Cost-effectiveness of deep brain stimulation versus treatment as usual for obsessive-compulsive disorder

Published:2017-07 Issue:4 Volume:10 Page:836-842
ISSN:1935-861X
Container-title:Brain Stimulation
language:en
Short-container-title:Brain Stimulation

Author:

Ooms Pieter,Blankers Matthijs,Figee Martijn,Bergfeld Isidoor O.,van den Munckhof Pepijn,Schuurman P. Richard,Denys Damiaan

Publisher

Elsevier BV

Subject

Clinical Neurology,Biophysics,General Neuroscience

Reference29 articles.

1. Quality of life in obsessive-compulsive disorder: impact of the disorder and of treatment;Subramaniam;CNS Drugs,2013

2. Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders;Denys;Psychiatr Clin North Am,2006

3. Current status of deep brain stimulation for obsessive-compulsive disorder: a clinical review of different targets;De Koning;Curr Psychiatry Rep,2011

4. Cost-effectiveness analysis alongside clinical trials II—an ISPOR good research practices task force report;Ramsey;Value Heal,2015

5. CCMO central committee on research involving human subjects. Behavioural research and the WMO. Man rev med res involv hum subj, den haag: committee on research involving human subjects,2002

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Public Perceptions of Neurotechnologies Used to Target Mood, Memory, and Motor Symptoms;2024-06-10

2. Cost-effectiveness and threshold analysis of deep brain stimulation vs. treatment-as-usual for treatment-resistant depression;Translational Psychiatry;2024-06-07

3. The persistent value of lesions in psychiatric neurosurgery;The Lancet Psychiatry;2024-06

4. Telemedicine in patients with obsessive–compulsive disorder after deep brain stimulation: a case series;Frontiers in Human Neuroscience;2024-02-14

5. The promise and challenges of transcranial magnetic stimulation and deep brain stimulation as therapeutic options for obsessive-compulsive disorder;Expert Review of Neurotherapeutics;2024-01-30